Serum tumor markers in small cell lung carcinoma patients treated with cyclophosphamide, epirubicin and vincristine combination

Turkish Journal of Cancer

Volumn 35, Issue 2, 2005, Pages 81-87

  Coşkun, Hasan Şenol ^a   Er, Özlem ^b   Altinbaş, Mustafa ^b   Özkan, Metin ^b   Soyuer, Serdar ^b  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Chemotherapy; NSE; Small cell lung cancer; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLOPHOSPHAMIDE; DALTEPARIN; EPIRUBICIN; FERRITIN; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; TUMOR MARKER; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; REMISSION; TREATMENT OUTCOME;

EID: 28244495897     PISSN: 10193103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cooper EH, Splinter TAW, Brown DA, et al. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer 1985;52:333-8.
2. Ferrigno D, Buccheri G, Biggi A. Serum tumour markers in lung cancer: History, biology and clinical applications. Eur Respir J 1994;7:186-97.
3. Cox R, Gyde OH, Leyland MJ. Serum ferritin levels in small cell lung cancer. Eur J Clin Oncol 1986;22:831-5.
4. Gronowitz JS, Bergström R, Nou E, et al. Clinical and serologic markers of stage and prognosis in small cell lung cancer. Cancer 1990;66:722-32.
5. Jaques G, Bepler G, Holle R, et al. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer. Cancer 1998;62:125-34.
6. Ferrigno D, Buccheri G. Comprehensive evaluation of serum ferritin levels in lung cancer patients. Lung Cancer 1992;8:85-94.
7. N.I.H. Carcinoembriyonic antigen: Its role as a marker in the management of cancer. Br Med J 1981;282:373-5.
8. Bonner JA, Sloan JA, Rowland KM, et al. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Clin Cancer Res 2000;6:597-601.
9. Pedersen AG, Bach FW, Nissen M, et al. Creatine kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer. J Clin Oncol 1985;10:1364-72.
10. Carney DN, Zweig MH, Ihde DC, et al. Elevated serum creatine kinase BB levels in patients with small cell lung cancer. Cancer Research 1984;44:5399-403.
11. Carney DN, Marangos DJ, Ihde DC, et al. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small cell lung cancer. Lancet 1982;1:583-5.
12. Ariyoshi Y, Kato K, Ishiguro Y, et al. Evaluation of serum neuron-specific enolase as a tumor marker far carcinoma of the lung. Gann 1983;74:219-25.
13. Esscher T, Steinholtz L, Bergh J, et al. Neuron specific enolase: a useful diagnostic serum marker for small cell carcinoma of lung. Thorax 1985;40:85-90.
14. Harding M, McAllister J, Hulks G, et al. Neuron-specific enolase (NSE) in small cell lung cancer. A tumour marker of prognostic significance? Br J Cancer 1990;61:605-7.
15. Jorgersen LG, Osterlind K, Genola J, et al. Serum neuron-specific enolase (S-NSE) and the prognosis in small cell lung cancer (SCLC): a combined multivariable analysis on data from nine centers. Br J Cancer 1996;74:463-7.
16. Cox R, Gyde OH, Leyland MJ. Serum ferritin levels in small cell lung cancer. Eur J Cancer Clin Oncol 1986;22:831-5.
17. Ferrigno D, Buccheri G. Serum ferritin levels in lung cancer patients. Eur J Cancer 1992;28:241.